

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 8.48273563 |
| 2 | central nervous system myelination (GO:0022010) | 8.48273563 |
| 3 | fatty acid elongation (GO:0030497) | 6.21380314 |
| 4 | ensheathment of neurons (GO:0007272) | 5.35396130 |
| 5 | axon ensheathment (GO:0008366) | 5.35396130 |
| 6 | myelination (GO:0042552) | 5.27020575 |
| 7 | DNA deamination (GO:0045006) | 5.13237402 |
| 8 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.08438732 |
| 9 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.64958697 |
| 10 | fucose catabolic process (GO:0019317) | 4.64724322 |
| 11 | L-fucose metabolic process (GO:0042354) | 4.64724322 |
| 12 | L-fucose catabolic process (GO:0042355) | 4.64724322 |
| 13 | response to methylmercury (GO:0051597) | 4.52630304 |
| 14 | establishment of mitochondrion localization (GO:0051654) | 4.38058679 |
| 15 | negative regulation of telomere maintenance (GO:0032205) | 4.37407194 |
| 16 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.24217350 |
| 17 | myelin maintenance (GO:0043217) | 4.22175257 |
| 18 | cholesterol biosynthetic process (GO:0006695) | 4.17835757 |
| 19 | heme biosynthetic process (GO:0006783) | 4.15939425 |
| 20 | oligodendrocyte differentiation (GO:0048709) | 4.02753309 |
| 21 | substantia nigra development (GO:0021762) | 4.00267246 |
| 22 | behavioral response to nicotine (GO:0035095) | 3.96447049 |
| 23 | regulation of collateral sprouting (GO:0048670) | 3.94757727 |
| 24 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.85398091 |
| 25 | amyloid precursor protein metabolic process (GO:0042982) | 3.84091276 |
| 26 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.82487679 |
| 27 | creatine metabolic process (GO:0006600) | 3.82250323 |
| 28 | chaperone-mediated protein transport (GO:0072321) | 3.79373453 |
| 29 | sterol biosynthetic process (GO:0016126) | 3.71547614 |
| 30 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.69773728 |
| 31 | presynaptic membrane organization (GO:0097090) | 3.63791019 |
| 32 | tetrapyrrole biosynthetic process (GO:0033014) | 3.63254609 |
| 33 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.60412754 |
| 34 | autophagic vacuole fusion (GO:0000046) | 3.60189472 |
| 35 | regulation of autophagic vacuole assembly (GO:2000785) | 3.56587261 |
| 36 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.55647332 |
| 37 | positive regulation of defense response to virus by host (GO:0002230) | 3.55288199 |
| 38 | heme metabolic process (GO:0042168) | 3.49636100 |
| 39 | negative regulation of neurotransmitter transport (GO:0051589) | 3.45650683 |
| 40 | glutathione biosynthetic process (GO:0006750) | 3.42537555 |
| 41 | positive regulation of action potential (GO:0045760) | 3.42416133 |
| 42 | photoreceptor cell differentiation (GO:0046530) | 3.35200095 |
| 43 | eye photoreceptor cell differentiation (GO:0001754) | 3.35200095 |
| 44 | indole-containing compound catabolic process (GO:0042436) | 3.31737851 |
| 45 | indolalkylamine catabolic process (GO:0046218) | 3.31737851 |
| 46 | tryptophan catabolic process (GO:0006569) | 3.31737851 |
| 47 | platelet dense granule organization (GO:0060155) | 3.26578896 |
| 48 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.22183223 |
| 49 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.21140885 |
| 50 | kynurenine metabolic process (GO:0070189) | 3.20164592 |
| 51 | porphyrin-containing compound metabolic process (GO:0006778) | 3.19943043 |
| 52 | magnesium ion transport (GO:0015693) | 3.18841417 |
| 53 | indolalkylamine metabolic process (GO:0006586) | 3.18363177 |
| 54 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.17171277 |
| 55 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.16160872 |
| 56 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.15488450 |
| 57 | detection of light stimulus involved in visual perception (GO:0050908) | 3.15488450 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 3.15392610 |
| 59 | regulation of vacuole organization (GO:0044088) | 3.15021582 |
| 60 | ATP synthesis coupled proton transport (GO:0015986) | 3.12729280 |
| 61 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.12729280 |
| 62 | presynaptic membrane assembly (GO:0097105) | 3.12054842 |
| 63 | peptidyl-cysteine modification (GO:0018198) | 3.11979453 |
| 64 | membrane tubulation (GO:0097320) | 3.10307850 |
| 65 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.09625685 |
| 66 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.09625685 |
| 67 | amyloid precursor protein catabolic process (GO:0042987) | 3.08804931 |
| 68 | response to redox state (GO:0051775) | 3.08096239 |
| 69 | GPI anchor biosynthetic process (GO:0006506) | 3.07610395 |
| 70 | metallo-sulfur cluster assembly (GO:0031163) | 3.07125175 |
| 71 | iron-sulfur cluster assembly (GO:0016226) | 3.07125175 |
| 72 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.05398848 |
| 73 | positive regulation of fatty acid transport (GO:2000193) | 3.04902134 |
| 74 | isoprenoid biosynthetic process (GO:0008299) | 3.04740770 |
| 75 | negative regulation of mast cell activation (GO:0033004) | 3.02391987 |
| 76 | nucleotide transmembrane transport (GO:1901679) | 3.01909527 |
| 77 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.01907803 |
| 78 | protein palmitoylation (GO:0018345) | 3.00880015 |
| 79 | glycerophospholipid catabolic process (GO:0046475) | 2.99631223 |
| 80 | cellular biogenic amine catabolic process (GO:0042402) | 2.99476681 |
| 81 | amine catabolic process (GO:0009310) | 2.99476681 |
| 82 | opioid receptor signaling pathway (GO:0038003) | 2.99257085 |
| 83 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.98323452 |
| 84 | adult walking behavior (GO:0007628) | 2.97757530 |
| 85 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.96927299 |
| 86 | cellular response to epinephrine stimulus (GO:0071872) | 2.96487715 |
| 87 | adaptation of signaling pathway (GO:0023058) | 2.95884781 |
| 88 | response to pheromone (GO:0019236) | 2.93867431 |
| 89 | iron coordination entity transport (GO:1901678) | 2.93820664 |
| 90 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.93785596 |
| 91 | apical protein localization (GO:0045176) | 2.93504090 |
| 92 | tryptophan metabolic process (GO:0006568) | 2.92380837 |
| 93 | respiratory chain complex IV assembly (GO:0008535) | 2.91736397 |
| 94 | respiratory electron transport chain (GO:0022904) | 2.91479586 |
| 95 | organelle membrane fusion (GO:0090174) | 2.90260210 |
| 96 | protein polyglutamylation (GO:0018095) | 2.90198233 |
| 97 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.88315904 |
| 98 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.88108709 |
| 99 | axon development (GO:0061564) | 2.87433181 |
| 100 | enteric nervous system development (GO:0048484) | 2.86951334 |
| 101 | electron transport chain (GO:0022900) | 2.86357995 |
| 102 | response to dietary excess (GO:0002021) | 2.85414990 |
| 103 | neuronal action potential propagation (GO:0019227) | 2.84253970 |
| 104 | response to lead ion (GO:0010288) | 2.82291908 |
| 105 | cytidine deamination (GO:0009972) | 2.82022318 |
| 106 | cytidine metabolic process (GO:0046087) | 2.82022318 |
| 107 | cytidine catabolic process (GO:0006216) | 2.82022318 |
| 108 | cornea development in camera-type eye (GO:0061303) | 2.81982015 |
| 109 | ketone body metabolic process (GO:1902224) | 2.81642713 |
| 110 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.80808791 |
| 111 | positive regulation of prostaglandin secretion (GO:0032308) | 2.78789359 |
| 112 | detection of temperature stimulus (GO:0016048) | 2.78690216 |
| 113 | inositol phosphate catabolic process (GO:0071545) | 2.78022957 |
| 114 | regulation of response to osmotic stress (GO:0047484) | 2.77651290 |
| 115 | peptide biosynthetic process (GO:0043043) | 2.76236541 |
| 116 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.75198583 |
| 117 | neuronal ion channel clustering (GO:0045161) | 2.73913710 |
| 118 | astrocyte development (GO:0014002) | 2.73766831 |
| 119 | GPI anchor metabolic process (GO:0006505) | 2.73230358 |
| 120 | heme transport (GO:0015886) | 2.72887416 |
| 121 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.70871866 |
| 122 | cytochrome complex assembly (GO:0017004) | 2.69944145 |
| 123 | signal peptide processing (GO:0006465) | 2.69276721 |
| 124 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.68945797 |
| 125 | negative regulation of axonogenesis (GO:0050771) | 2.68856587 |
| 126 | piRNA metabolic process (GO:0034587) | 2.67779393 |
| 127 | proline transport (GO:0015824) | 2.66736420 |
| 128 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.66099009 |
| 129 | adhesion of symbiont to host cell (GO:0044650) | 2.65795308 |
| 130 | virion attachment to host cell (GO:0019062) | 2.65795308 |
| 131 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.65622139 |
| 132 | regulation of lipoprotein metabolic process (GO:0050746) | 2.65619818 |
| 133 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.65615508 |
| 134 | synaptic vesicle exocytosis (GO:0016079) | 2.65577306 |
| 135 | positive regulation of icosanoid secretion (GO:0032305) | 2.65267789 |
| 136 | regulation of memory T cell differentiation (GO:0043380) | 2.64750121 |
| 137 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.64370234 |
| 138 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.64365426 |
| 139 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.64365426 |
| 140 | NADH dehydrogenase complex assembly (GO:0010257) | 2.64365426 |
| 141 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.63421925 |
| 142 | mitochondrion transport along microtubule (GO:0047497) | 2.63421925 |
| 143 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.63418846 |
| 144 | synaptic vesicle maturation (GO:0016188) | 2.62574505 |
| 145 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.62098508 |
| 146 | inositol phosphate dephosphorylation (GO:0046855) | 2.62039630 |
| 147 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.62039630 |
| 148 | protein complex biogenesis (GO:0070271) | 2.61811515 |
| 149 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.60508808 |
| 150 | neural nucleus development (GO:0048857) | 2.59316516 |
| 151 | protein maturation by protein folding (GO:0022417) | 2.58542080 |
| 152 | mannosylation (GO:0097502) | 2.58204893 |
| 153 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.55868873 |
| 154 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.55597687 |
| 155 | nucleoside transmembrane transport (GO:1901642) | 2.53699522 |
| 156 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.53461463 |
| 157 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.52451849 |
| 158 | response to lipoprotein particle (GO:0055094) | 2.52421338 |
| 159 | regulation of defense response to virus by host (GO:0050691) | 2.51173059 |
| 160 | NAD biosynthetic process (GO:0009435) | 2.50176933 |
| 161 | regulation of telomere maintenance (GO:0032204) | 2.49410618 |
| 162 | protein K6-linked ubiquitination (GO:0085020) | 2.49022992 |
| 163 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.48897702 |
| 164 | negative regulation of multicellular organism growth (GO:0040015) | 2.48409069 |
| 165 | parturition (GO:0007567) | 2.45808072 |
| 166 | polyol catabolic process (GO:0046174) | 2.45782325 |
| 167 | DNA methylation involved in gamete generation (GO:0043046) | 2.45252108 |
| 168 | ubiquinone biosynthetic process (GO:0006744) | 2.44575169 |
| 169 | glycine transport (GO:0015816) | 2.43298248 |
| 170 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.42407140 |
| 171 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.41738127 |
| 172 | rhodopsin mediated signaling pathway (GO:0016056) | 2.38813645 |
| 173 | multicellular organism reproduction (GO:0032504) | 2.36784448 |
| 174 | oxidative demethylation (GO:0070989) | 2.36592580 |
| 175 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.36152033 |
| 176 | regulation of cilium movement (GO:0003352) | 2.35909610 |
| 177 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.35115927 |
| 178 | indole-containing compound metabolic process (GO:0042430) | 2.35009354 |
| 179 | S-adenosylmethionine metabolic process (GO:0046500) | 2.34795437 |
| 180 | alanine transport (GO:0032328) | 2.34075557 |
| 181 | C-terminal protein lipidation (GO:0006501) | 2.33933372 |
| 182 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.32859055 |
| 183 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.32064998 |
| 184 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.31980324 |
| 185 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.31778144 |
| 186 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.31762152 |
| 187 | pseudouridine synthesis (GO:0001522) | 2.28215208 |
| 188 | anterograde synaptic vesicle transport (GO:0048490) | 2.26554765 |
| 189 | positive regulation of protein homooligomerization (GO:0032464) | 2.25384979 |
| 190 | regulation of hippo signaling (GO:0035330) | 2.24324407 |
| 191 | axoneme assembly (GO:0035082) | 2.24145578 |
| 192 | C-terminal protein amino acid modification (GO:0018410) | 2.23450391 |
| 193 | auditory receptor cell stereocilium organization (GO:0060088) | 2.23188635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 5.11677578 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.71674608 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.29046088 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.04365653 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.60286414 |
| 6 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.74561956 |
| 7 | GATA1_19941826_ChIP-Seq_K562_Human | 2.32762816 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.20203151 |
| 9 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.98874084 |
| 10 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97475122 |
| 11 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.96971520 |
| 12 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.92097366 |
| 13 | ERA_21632823_ChIP-Seq_H3396_Human | 1.90069937 |
| 14 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.89027533 |
| 15 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.88521211 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.87066264 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 1.86073604 |
| 18 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.81978822 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.79636537 |
| 20 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.73169551 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.71942665 |
| 22 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.71223441 |
| 23 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.71004224 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.68493153 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.67881357 |
| 26 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.67092072 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.66017613 |
| 28 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.64914912 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63950787 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.63614319 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61273573 |
| 32 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.61172758 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.60937291 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.60176519 |
| 35 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.60151373 |
| 36 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.58784196 |
| 37 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.57131405 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.56638095 |
| 39 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.53377677 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.51668762 |
| 41 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.51154101 |
| 42 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.51001496 |
| 43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.48101579 |
| 44 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.47586167 |
| 45 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.45827809 |
| 46 | P300_27268052_Chip-Seq_Bcells_Human | 1.45406317 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.44452601 |
| 48 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.43711141 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43559987 |
| 50 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.41386686 |
| 51 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.39981372 |
| 52 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.38675814 |
| 53 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.38572929 |
| 54 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.38193253 |
| 55 | NCOR_22424771_ChIP-Seq_293T_Human | 1.37609227 |
| 56 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.37035967 |
| 57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36241415 |
| 58 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.35741228 |
| 59 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.35597610 |
| 60 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.34692514 |
| 61 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.34564865 |
| 62 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.31568244 |
| 63 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.30467118 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29291247 |
| 65 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.29088930 |
| 66 | AR_20517297_ChIP-Seq_VCAP_Human | 1.28504043 |
| 67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28364428 |
| 68 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28005504 |
| 69 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.27272724 |
| 70 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.27272724 |
| 71 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.26390489 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25418516 |
| 73 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.25400283 |
| 74 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25275891 |
| 75 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24995119 |
| 76 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24406795 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23436707 |
| 78 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.22542669 |
| 79 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.21283647 |
| 80 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.21240474 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21050795 |
| 82 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20810278 |
| 83 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.20347856 |
| 84 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.20109118 |
| 85 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.19373198 |
| 86 | P68_20966046_ChIP-Seq_HELA_Human | 1.19345662 |
| 87 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.19078879 |
| 88 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.17789282 |
| 89 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.17707694 |
| 90 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.16643311 |
| 91 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.16328701 |
| 92 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.15748082 |
| 93 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15127150 |
| 94 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14990216 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14483505 |
| 96 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14235950 |
| 97 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14089029 |
| 98 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.13874113 |
| 99 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13523835 |
| 100 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13004276 |
| 101 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12898058 |
| 102 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.10850057 |
| 103 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.10803135 |
| 104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10699135 |
| 105 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.10617617 |
| 106 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.10251233 |
| 107 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10049435 |
| 108 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09068007 |
| 109 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.08587021 |
| 110 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07139759 |
| 111 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06102659 |
| 112 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 1.05679487 |
| 113 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.04883078 |
| 114 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04287514 |
| 115 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.04034392 |
| 116 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.03359928 |
| 117 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03124407 |
| 118 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.02863791 |
| 119 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.02535466 |
| 120 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.01121186 |
| 121 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.01090022 |
| 122 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.00697102 |
| 123 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.00171741 |
| 124 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.00156921 |
| 125 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.00149066 |
| 126 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99921991 |
| 127 | * CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.99647188 |
| 128 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99575980 |
| 129 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.98948535 |
| 130 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.98522147 |
| 131 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98501789 |
| 132 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.98441677 |
| 133 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97441031 |
| 134 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.97039595 |
| 135 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96677248 |
| 136 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95857620 |
| 137 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95764316 |
| 138 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95589074 |
| 139 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95194518 |
| 140 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.94586827 |
| 141 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93595904 |
| 142 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93493864 |
| 143 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.93306877 |
| 144 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.93277546 |
| 145 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.92866346 |
| 146 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92640320 |
| 147 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.92508485 |
| 148 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.92084088 |
| 149 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.92034728 |
| 150 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91754729 |
| 151 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.91028148 |
| 152 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.90714778 |
| 153 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.90032810 |
| 154 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.89842233 |
| 155 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.89746894 |
| 156 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.89301839 |
| 157 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88179897 |
| 158 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.87274566 |
| 159 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.86632595 |
| 160 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86460792 |
| 161 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85915481 |
| 162 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.84843607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.43661255 |
| 2 | MP0003880_abnormal_central_pattern | 4.12764441 |
| 3 | MP0003656_abnormal_erythrocyte_physiolo | 3.71818051 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.50520949 |
| 5 | MP0004147_increased_porphyrin_level | 3.42606574 |
| 6 | MP0004270_analgesia | 3.09755302 |
| 7 | MP0001529_abnormal_vocalization | 2.99795497 |
| 8 | MP0001905_abnormal_dopamine_level | 2.72478152 |
| 9 | MP0003329_amyloid_beta_deposits | 2.64480078 |
| 10 | MP0002272_abnormal_nervous_system | 2.62792466 |
| 11 | MP0003787_abnormal_imprinting | 2.58171669 |
| 12 | MP0002653_abnormal_ependyma_morphology | 2.43109371 |
| 13 | MP0002064_seizures | 2.39692508 |
| 14 | MP0006292_abnormal_olfactory_placode | 2.37562234 |
| 15 | MP0005645_abnormal_hypothalamus_physiol | 2.30741311 |
| 16 | MP0004142_abnormal_muscle_tone | 2.28512911 |
| 17 | MP0004043_abnormal_pH_regulation | 2.24966081 |
| 18 | MP0003646_muscle_fatigue | 2.21926006 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.19504858 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.15758684 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.15635302 |
| 22 | MP0009745_abnormal_behavioral_response | 2.11030127 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 2.10029506 |
| 24 | MP0003011_delayed_dark_adaptation | 2.01229279 |
| 25 | MP0001970_abnormal_pain_threshold | 2.01169549 |
| 26 | MP0003635_abnormal_synaptic_transmissio | 1.99682410 |
| 27 | MP0003690_abnormal_glial_cell | 1.99462934 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.98715194 |
| 29 | MP0008260_abnormal_autophagy | 1.98663324 |
| 30 | MP0003634_abnormal_glial_cell | 1.91527751 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.89329756 |
| 32 | MP0002102_abnormal_ear_morphology | 1.86733411 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.86563951 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.85874372 |
| 35 | MP0000462_abnormal_digestive_system | 1.84932788 |
| 36 | MP0002736_abnormal_nociception_after | 1.84417269 |
| 37 | MP0002735_abnormal_chemical_nociception | 1.83605236 |
| 38 | MP0002876_abnormal_thyroid_physiology | 1.81527244 |
| 39 | MP0004742_abnormal_vestibular_system | 1.81304066 |
| 40 | MP0002229_neurodegeneration | 1.79060638 |
| 41 | MP0008872_abnormal_physiological_respon | 1.75721758 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.75099471 |
| 43 | MP0000685_abnormal_immune_system | 1.68431907 |
| 44 | MP0009046_muscle_twitch | 1.67879125 |
| 45 | MP0001486_abnormal_startle_reflex | 1.65798290 |
| 46 | MP0005671_abnormal_response_to | 1.65471988 |
| 47 | MP0004885_abnormal_endolymph | 1.64095855 |
| 48 | MP0003195_calcinosis | 1.63962812 |
| 49 | MP0001873_stomach_inflammation | 1.63476609 |
| 50 | MP0002572_abnormal_emotion/affect_behav | 1.61760878 |
| 51 | MP0001440_abnormal_grooming_behavior | 1.61275555 |
| 52 | MP0005171_absent_coat_pigmentation | 1.60911485 |
| 53 | MP0008875_abnormal_xenobiotic_pharmacok | 1.52922386 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.51572478 |
| 55 | MP0002063_abnormal_learning/memory/cond | 1.50071610 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.49511730 |
| 57 | MP0000372_irregular_coat_pigmentation | 1.47576986 |
| 58 | MP0009840_abnormal_foam_cell | 1.43988550 |
| 59 | MP0003633_abnormal_nervous_system | 1.43667070 |
| 60 | MP0001485_abnormal_pinna_reflex | 1.40731023 |
| 61 | MP0002163_abnormal_gland_morphology | 1.39189599 |
| 62 | MP0005083_abnormal_biliary_tract | 1.38477188 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.36578127 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 1.35657597 |
| 65 | MP0008569_lethality_at_weaning | 1.35089478 |
| 66 | MP0005387_immune_system_phenotype | 1.34117457 |
| 67 | MP0001790_abnormal_immune_system | 1.34117457 |
| 68 | MP0009764_decreased_sensitivity_to | 1.33990770 |
| 69 | MP0000604_amyloidosis | 1.33727701 |
| 70 | MP0005451_abnormal_body_composition | 1.33137206 |
| 71 | MP0002148_abnormal_hypersensitivity_rea | 1.33031254 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 1.32564402 |
| 73 | MP0001800_abnormal_humoral_immune | 1.32330093 |
| 74 | MP0000569_abnormal_digit_pigmentation | 1.29846234 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 1.29728282 |
| 76 | MP0003631_nervous_system_phenotype | 1.28758534 |
| 77 | MP0005174_abnormal_tail_pigmentation | 1.27992910 |
| 78 | MP0002066_abnormal_motor_capabilities/c | 1.25093473 |
| 79 | MP0002928_abnormal_bile_duct | 1.22138542 |
| 80 | MP0002067_abnormal_sensory_capabilities | 1.21894847 |
| 81 | MP0002723_abnormal_immune_serum | 1.21138764 |
| 82 | MP0000955_abnormal_spinal_cord | 1.20166539 |
| 83 | MP0002882_abnormal_neuron_morphology | 1.20075848 |
| 84 | MP0005365_abnormal_bile_salt | 1.18039884 |
| 85 | MP0005670_abnormal_white_adipose | 1.16233724 |
| 86 | MP0000015_abnormal_ear_pigmentation | 1.13074469 |
| 87 | MP0000778_abnormal_nervous_system | 1.11751888 |
| 88 | MP0002693_abnormal_pancreas_physiology | 1.11584060 |
| 89 | MP0003724_increased_susceptibility_to | 1.10213716 |
| 90 | MP0003632_abnormal_nervous_system | 1.09605669 |
| 91 | MP0006072_abnormal_retinal_apoptosis | 1.07927891 |
| 92 | MP0005075_abnormal_melanosome_morpholog | 1.07852536 |
| 93 | MP0004924_abnormal_behavior | 1.07802126 |
| 94 | MP0005386_behavior/neurological_phenoty | 1.07802126 |
| 95 | MP0002420_abnormal_adaptive_immunity | 1.07225862 |
| 96 | MP0001819_abnormal_immune_cell | 1.06587577 |
| 97 | MP0002822_catalepsy | 1.06186160 |
| 98 | MP0000747_muscle_weakness | 1.05325053 |
| 99 | MP0002452_abnormal_antigen_presenting | 1.04242796 |
| 100 | MP0000427_abnormal_hair_cycle | 1.03030599 |
| 101 | MP0000631_abnormal_neuroendocrine_gland | 1.01085473 |
| 102 | MP0005423_abnormal_somatic_nervous | 1.00275248 |
| 103 | MP0004811_abnormal_neuron_physiology | 0.99922724 |
| 104 | MP0002751_abnormal_autonomic_nervous | 0.99502134 |
| 105 | MP0005409_darkened_coat_color | 0.98217022 |
| 106 | MP0001764_abnormal_homeostasis | 0.97790147 |
| 107 | MP0005000_abnormal_immune_tolerance | 0.97637134 |
| 108 | MP0004130_abnormal_muscle_cell | 0.97409434 |
| 109 | MP0000749_muscle_degeneration | 0.97116297 |
| 110 | MP0005410_abnormal_fertilization | 0.94757079 |
| 111 | MP0005448_abnormal_energy_balance | 0.94444217 |
| 112 | MP0010329_abnormal_lipoprotein_level | 0.93874474 |
| 113 | MP0009785_altered_susceptibility_to | 0.92006507 |
| 114 | MP0005332_abnormal_amino_acid | 0.90413743 |
| 115 | MP0003172_abnormal_lysosome_physiology | 0.90223223 |
| 116 | MP0006276_abnormal_autonomic_nervous | 0.89961314 |
| 117 | MP0005636_abnormal_mineral_homeostasis | 0.89340503 |
| 118 | MP0003950_abnormal_plasma_membrane | 0.89251792 |
| 119 | MP0005025_abnormal_response_to | 0.88648169 |
| 120 | MP0010386_abnormal_urinary_bladder | 0.86698818 |
| 121 | MP0003075_altered_response_to | 0.86352508 |
| 122 | MP0002938_white_spotting | 0.86077913 |
| 123 | MP0001663_abnormal_digestive_system | 0.85881280 |
| 124 | MP0002090_abnormal_vision | 0.85626105 |
| 125 | MP0001963_abnormal_hearing_physiology | 0.84647785 |
| 126 | MP0001502_abnormal_circadian_rhythm | 0.84437101 |
| 127 | MP0002752_abnormal_somatic_nervous | 0.84412614 |
| 128 | MP0005085_abnormal_gallbladder_physiolo | 0.83782938 |
| 129 | MP0003137_abnormal_impulse_conducting | 0.83492079 |
| 130 | MP0008874_decreased_physiological_sensi | 0.82996679 |
| 131 | MP0005084_abnormal_gallbladder_morpholo | 0.82968127 |
| 132 | MP0006082_CNS_inflammation | 0.82362459 |
| 133 | MP0001919_abnormal_reproductive_system | 0.82107956 |
| 134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81520672 |
| 135 | MP0002095_abnormal_skin_pigmentation | 0.80767378 |
| 136 | MP0001765_abnormal_ion_homeostasis | 0.78867984 |
| 137 | MP0005310_abnormal_salivary_gland | 0.77678381 |
| 138 | MP0000230_abnormal_systemic_arterial | 0.77380954 |
| 139 | MP0003879_abnormal_hair_cell | 0.75976899 |
| 140 | MP0008789_abnormal_olfactory_epithelium | 0.75713203 |
| 141 | MP0000716_abnormal_immune_system | 0.75141420 |
| 142 | MP0001501_abnormal_sleep_pattern | 0.75034795 |
| 143 | MP0008995_early_reproductive_senescence | 0.75026822 |
| 144 | MP0000639_abnormal_adrenal_gland | 0.71004509 |
| 145 | MP0002557_abnormal_social/conspecific_i | 0.70538234 |
| 146 | MP0003186_abnormal_redox_activity | 0.70513468 |
| 147 | MP0005379_endocrine/exocrine_gland_phen | 0.69654956 |
| 148 | MP0001188_hyperpigmentation | 0.68240687 |
| 149 | MP0003122_maternal_imprinting | 0.67566305 |
| 150 | MP0009333_abnormal_splenocyte_physiolog | 0.67443844 |
| 151 | MP0005195_abnormal_posterior_eye | 0.67388192 |
| 152 | MP0000013_abnormal_adipose_tissue | 0.66914824 |
| 153 | MP0005253_abnormal_eye_physiology | 0.66851654 |
| 154 | MP0003183_abnormal_peptide_metabolism | 0.65463387 |
| 155 | MP0009765_abnormal_xenobiotic_induced | 0.65006439 |
| 156 | MP0008873_increased_physiological_sensi | 0.63581805 |
| 157 | MP0004133_heterotaxia | 0.62731421 |
| 158 | MP0001984_abnormal_olfaction | 0.62633154 |
| 159 | MP0001346_abnormal_lacrimal_gland | 0.61304440 |
| 160 | MP0000003_abnormal_adipose_tissue | 0.60166318 |
| 161 | MP0002184_abnormal_innervation | 0.59990721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral hypomyelination (HP:0006808) | 5.21038655 |
| 2 | Sensory axonal neuropathy (HP:0003390) | 4.91312920 |
| 3 | Congenital stationary night blindness (HP:0007642) | 4.83044866 |
| 4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.33685921 |
| 5 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.33685921 |
| 6 | Neurofibrillary tangles (HP:0002185) | 4.31579024 |
| 7 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.08021774 |
| 8 | Stomatitis (HP:0010280) | 3.93875823 |
| 9 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.84248068 |
| 10 | Molar tooth sign on MRI (HP:0002419) | 3.75421369 |
| 11 | Abnormality of midbrain morphology (HP:0002418) | 3.75421369 |
| 12 | Peripheral hypomyelination (HP:0007182) | 3.69648517 |
| 13 | Myokymia (HP:0002411) | 3.68081641 |
| 14 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.56912121 |
| 15 | Parakeratosis (HP:0001036) | 3.42836564 |
| 16 | Spastic paraparesis (HP:0002313) | 3.41991741 |
| 17 | Abnormality of glycolysis (HP:0004366) | 3.34630056 |
| 18 | Increased serum pyruvate (HP:0003542) | 3.34630056 |
| 19 | Pancreatic cysts (HP:0001737) | 3.29378605 |
| 20 | Retinal dysplasia (HP:0007973) | 3.18609143 |
| 21 | Leukodystrophy (HP:0002415) | 3.16704802 |
| 22 | Abnormality of the corticospinal tract (HP:0002492) | 3.16047169 |
| 23 | Spastic gait (HP:0002064) | 3.11144754 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 3.08448106 |
| 25 | Hepatocellular necrosis (HP:0001404) | 3.02325440 |
| 26 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.99557788 |
| 27 | Acute necrotizing encephalopathy (HP:0006965) | 2.99041641 |
| 28 | Cerebral inclusion bodies (HP:0100314) | 2.94020964 |
| 29 | Attenuation of retinal blood vessels (HP:0007843) | 2.93123496 |
| 30 | Scanning speech (HP:0002168) | 2.85860606 |
| 31 | CNS hypomyelination (HP:0003429) | 2.84147912 |
| 32 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.82881313 |
| 33 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.79683230 |
| 34 | Nephronophthisis (HP:0000090) | 2.75143156 |
| 35 | Mitochondrial inheritance (HP:0001427) | 2.74367637 |
| 36 | Pancreatic fibrosis (HP:0100732) | 2.74005548 |
| 37 | True hermaphroditism (HP:0010459) | 2.69253398 |
| 38 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69041323 |
| 39 | Onion bulb formation (HP:0003383) | 2.68843516 |
| 40 | Hyperventilation (HP:0002883) | 2.67961334 |
| 41 | Dysmetria (HP:0001310) | 2.67439945 |
| 42 | Stomach cancer (HP:0012126) | 2.65502672 |
| 43 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.64271594 |
| 44 | Epileptic encephalopathy (HP:0200134) | 2.63087396 |
| 45 | Abnormality of the renal cortex (HP:0011035) | 2.62648433 |
| 46 | Progressive microcephaly (HP:0000253) | 2.61437517 |
| 47 | Abolished electroretinogram (ERG) (HP:0000550) | 2.59970769 |
| 48 | Slow saccadic eye movements (HP:0000514) | 2.57678144 |
| 49 | 3-Methylglutaconic aciduria (HP:0003535) | 2.57546258 |
| 50 | Ankle clonus (HP:0011448) | 2.57331605 |
| 51 | Acute encephalopathy (HP:0006846) | 2.54319692 |
| 52 | Poor suck (HP:0002033) | 2.53061890 |
| 53 | Intention tremor (HP:0002080) | 2.52997028 |
| 54 | Large for gestational age (HP:0001520) | 2.52981110 |
| 55 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.51267841 |
| 56 | Severe visual impairment (HP:0001141) | 2.47391033 |
| 57 | Hepatic necrosis (HP:0002605) | 2.46655489 |
| 58 | Polydipsia (HP:0001959) | 2.45936590 |
| 59 | Abnormal drinking behavior (HP:0030082) | 2.45936590 |
| 60 | Type II lissencephaly (HP:0007260) | 2.45769861 |
| 61 | Inability to walk (HP:0002540) | 2.44591831 |
| 62 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.43869825 |
| 63 | Abnormal auditory evoked potentials (HP:0006958) | 2.41614214 |
| 64 | Abnormal gallbladder morphology (HP:0012437) | 2.39372366 |
| 65 | Abnormality of the renal medulla (HP:0100957) | 2.38109432 |
| 66 | Clumsiness (HP:0002312) | 2.38094427 |
| 67 | Medial flaring of the eyebrow (HP:0010747) | 2.36407443 |
| 68 | Increased circulating renin level (HP:0000848) | 2.34166977 |
| 69 | Atonic seizures (HP:0010819) | 2.33273569 |
| 70 | Poikilocytosis (HP:0004447) | 2.32258015 |
| 71 | Pheochromocytoma (HP:0002666) | 2.30709883 |
| 72 | Neuroendocrine neoplasm (HP:0100634) | 2.28656697 |
| 73 | Diaphragmatic weakness (HP:0009113) | 2.26996326 |
| 74 | Anteriorly placed anus (HP:0001545) | 2.26604116 |
| 75 | Methylmalonic acidemia (HP:0002912) | 2.26004041 |
| 76 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.23995904 |
| 77 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23548539 |
| 78 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23548539 |
| 79 | Paraparesis (HP:0002385) | 2.22881827 |
| 80 | Stridor (HP:0010307) | 2.22765370 |
| 81 | Abnormality of magnesium homeostasis (HP:0004921) | 2.21374999 |
| 82 | Decreased central vision (HP:0007663) | 2.20482669 |
| 83 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.20025442 |
| 84 | Abnormality of alanine metabolism (HP:0010916) | 2.20025442 |
| 85 | Hyperalaninemia (HP:0003348) | 2.20025442 |
| 86 | Poor speech (HP:0002465) | 2.18310953 |
| 87 | Progressive macrocephaly (HP:0004481) | 2.16228663 |
| 88 | Cerebral hemorrhage (HP:0001342) | 2.15508197 |
| 89 | Cholecystitis (HP:0001082) | 2.15376691 |
| 90 | Abnormal gallbladder physiology (HP:0012438) | 2.15376691 |
| 91 | Akinesia (HP:0002304) | 2.15122829 |
| 92 | Progressive neurologic deterioration (HP:0002344) | 2.15106847 |
| 93 | Increased CSF lactate (HP:0002490) | 2.14701869 |
| 94 | Alacrima (HP:0000522) | 2.13589435 |
| 95 | Limb dystonia (HP:0002451) | 2.12852344 |
| 96 | Renal Fanconi syndrome (HP:0001994) | 2.12458263 |
| 97 | Progressive inability to walk (HP:0002505) | 2.11180098 |
| 98 | Absent speech (HP:0001344) | 2.10503345 |
| 99 | Cystic liver disease (HP:0006706) | 2.09348786 |
| 100 | Gaze-evoked nystagmus (HP:0000640) | 2.07790387 |
| 101 | Cholelithiasis (HP:0001081) | 2.06504118 |
| 102 | Agammaglobulinemia (HP:0004432) | 2.05391416 |
| 103 | Severe muscular hypotonia (HP:0006829) | 2.04774060 |
| 104 | Morphological abnormality of the inner ear (HP:0011390) | 2.04725241 |
| 105 | Chronic hepatic failure (HP:0100626) | 2.04661823 |
| 106 | Thyroid-stimulating hormone excess (HP:0002925) | 2.03788066 |
| 107 | Progressive cerebellar ataxia (HP:0002073) | 2.03245987 |
| 108 | Choreoathetosis (HP:0001266) | 2.03063522 |
| 109 | Panhypogammaglobulinemia (HP:0003139) | 2.02717657 |
| 110 | Thickened helices (HP:0000391) | 2.02469201 |
| 111 | Paralysis (HP:0003470) | 2.01323024 |
| 112 | Polyuria (HP:0000103) | 2.00710629 |
| 113 | Acanthocytosis (HP:0001927) | 1.99627162 |
| 114 | Albinism (HP:0001022) | 1.99478361 |
| 115 | Bile duct proliferation (HP:0001408) | 1.99375876 |
| 116 | Abnormal biliary tract physiology (HP:0012439) | 1.99375876 |
| 117 | Hypoplasia of the fovea (HP:0007750) | 1.98685314 |
| 118 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.98685314 |
| 119 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98020832 |
| 120 | Neoplasm of the adrenal cortex (HP:0100641) | 1.97950366 |
| 121 | Decreased circulating renin level (HP:0003351) | 1.97863155 |
| 122 | Delusions (HP:0000746) | 1.97697074 |
| 123 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.97494526 |
| 124 | Increased serum lactate (HP:0002151) | 1.96718328 |
| 125 | Hypochromic anemia (HP:0001931) | 1.94738645 |
| 126 | Premature skin wrinkling (HP:0100678) | 1.94617371 |
| 127 | Sclerocornea (HP:0000647) | 1.93278100 |
| 128 | Bulbous nose (HP:0000414) | 1.92946080 |
| 129 | Constricted visual fields (HP:0001133) | 1.91633530 |
| 130 | Ketosis (HP:0001946) | 1.91268776 |
| 131 | Anxiety (HP:0000739) | 1.91027619 |
| 132 | Emotional lability (HP:0000712) | 1.90860781 |
| 133 | Recurrent fungal infections (HP:0002841) | 1.89878209 |
| 134 | Abnormal eating behavior (HP:0100738) | 1.89523070 |
| 135 | Opisthotonus (HP:0002179) | 1.89378594 |
| 136 | Focal motor seizures (HP:0011153) | 1.88731627 |
| 137 | Cutaneous photosensitivity (HP:0000992) | 1.88366649 |
| 138 | Renal cortical cysts (HP:0000803) | 1.88015611 |
| 139 | Pachygyria (HP:0001302) | 1.87920232 |
| 140 | Amelogenesis imperfecta (HP:0000705) | 1.87292914 |
| 141 | Hypomagnesemia (HP:0002917) | 1.87194107 |
| 142 | Tubular atrophy (HP:0000092) | 1.87065001 |
| 143 | Abnormality of macular pigmentation (HP:0008002) | 1.86890098 |
| 144 | Hyperglycinuria (HP:0003108) | 1.86794982 |
| 145 | Purpura (HP:0000979) | 1.86585301 |
| 146 | Generalized myoclonic seizures (HP:0002123) | 1.84992841 |
| 147 | Abnormality of T cell physiology (HP:0011840) | 1.84529474 |
| 148 | Psychosis (HP:0000709) | 1.83613316 |
| 149 | Methylmalonic aciduria (HP:0012120) | 1.83486895 |
| 150 | Pendular nystagmus (HP:0012043) | 1.83344252 |
| 151 | Increased hepatocellular lipid droplets (HP:0006565) | 1.81670883 |
| 152 | Muscular hypotonia of the trunk (HP:0008936) | 1.81341094 |
| 153 | Encephalitis (HP:0002383) | 1.81184659 |
| 154 | Hemiparesis (HP:0001269) | 1.81122127 |
| 155 | IgG deficiency (HP:0004315) | 1.81041660 |
| 156 | Lissencephaly (HP:0001339) | 1.80661187 |
| 157 | Respiratory failure (HP:0002878) | 1.80558200 |
| 158 | Chronic otitis media (HP:0000389) | 1.80517133 |
| 159 | Clonus (HP:0002169) | 1.79581810 |
| 160 | Cerebellar dysplasia (HP:0007033) | 1.79449319 |
| 161 | Hyperbilirubinemia (HP:0002904) | 1.79179273 |
| 162 | Hepatosplenomegaly (HP:0001433) | 1.78393431 |
| 163 | Hypothermia (HP:0002045) | 1.78226294 |
| 164 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76914019 |
| 165 | Retinitis pigmentosa (HP:0000510) | 1.76832979 |
| 166 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.76792247 |
| 167 | Retrobulbar optic neuritis (HP:0100654) | 1.76176505 |
| 168 | Optic neuritis (HP:0100653) | 1.76176505 |
| 169 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.75944973 |
| 170 | Termporal pattern (HP:0011008) | 1.75761603 |
| 171 | Insidious onset (HP:0003587) | 1.75761603 |
| 172 | Visual hallucinations (HP:0002367) | 1.75639266 |
| 173 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.75300344 |
| 174 | Gait imbalance (HP:0002141) | 1.75036153 |
| 175 | Episodic fever (HP:0001954) | 1.74404837 |
| 176 | Cortical visual impairment (HP:0100704) | 1.74175978 |
| 177 | Optic disc pallor (HP:0000543) | 1.74077719 |
| 178 | Abnormal number of erythroid precursors (HP:0012131) | 1.73733898 |
| 179 | Febrile seizures (HP:0002373) | 1.73532967 |
| 180 | Rigidity (HP:0002063) | 1.72555972 |
| 181 | Broad-based gait (HP:0002136) | 1.71466095 |
| 182 | Cerebral palsy (HP:0100021) | 1.71361051 |
| 183 | Postnatal microcephaly (HP:0005484) | 1.70741240 |
| 184 | Lipid accumulation in hepatocytes (HP:0006561) | 1.68382324 |
| 185 | Vacuolated lymphocytes (HP:0001922) | 1.68375858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.83964093 |
| 2 | STK39 | 4.05103991 |
| 3 | MAP4K2 | 3.66283034 |
| 4 | OXSR1 | 3.41826586 |
| 5 | MAP3K13 | 3.29693187 |
| 6 | TNIK | 3.20897590 |
| 7 | CDK19 | 3.20288811 |
| 8 | ZAK | 3.13945947 |
| 9 | TAOK3 | 3.06186138 |
| 10 | BMPR1B | 2.69864080 |
| 11 | ARAF | 2.62604686 |
| 12 | GRK1 | 2.52260004 |
| 13 | EPHB1 | 2.39508732 |
| 14 | STK16 | 2.36791168 |
| 15 | MAPK15 | 2.25784473 |
| 16 | UHMK1 | 2.22904348 |
| 17 | MAPKAPK5 | 2.11410148 |
| 18 | NUAK1 | 2.05147398 |
| 19 | TNK2 | 2.01799542 |
| 20 | ICK | 1.97223492 |
| 21 | LIMK1 | 1.94923725 |
| 22 | PKN1 | 1.91905531 |
| 23 | BCR | 1.88635841 |
| 24 | WNK4 | 1.88592848 |
| 25 | TXK | 1.85965962 |
| 26 | CSNK1G3 | 1.79745488 |
| 27 | PBK | 1.79105654 |
| 28 | MAPKAPK3 | 1.73015717 |
| 29 | TESK2 | 1.71563219 |
| 30 | NTRK1 | 1.64941710 |
| 31 | CAMK2B | 1.58004605 |
| 32 | IKBKB | 1.55949358 |
| 33 | CASK | 1.55843995 |
| 34 | VRK2 | 1.44301646 |
| 35 | MST4 | 1.43771844 |
| 36 | ADRBK2 | 1.41681683 |
| 37 | CSNK1A1L | 1.38628474 |
| 38 | KIT | 1.36635190 |
| 39 | PRPF4B | 1.34932599 |
| 40 | KSR2 | 1.34831720 |
| 41 | INSRR | 1.28558257 |
| 42 | ACVR1B | 1.25931254 |
| 43 | CAMK2D | 1.24043438 |
| 44 | CSNK1G1 | 1.23242266 |
| 45 | BRAF | 1.21585815 |
| 46 | CSNK1G2 | 1.21155876 |
| 47 | MET | 1.19280346 |
| 48 | WNK3 | 1.16750212 |
| 49 | CDK14 | 1.12793351 |
| 50 | PHKG1 | 1.12051590 |
| 51 | PHKG2 | 1.12051590 |
| 52 | MAP3K9 | 1.10950707 |
| 53 | PTK2B | 1.10019633 |
| 54 | ADRBK1 | 1.09035257 |
| 55 | SGK223 | 1.07478025 |
| 56 | SGK494 | 1.07478025 |
| 57 | CAMK2G | 1.07359737 |
| 58 | ROCK2 | 1.06183193 |
| 59 | EPHA4 | 1.05116366 |
| 60 | CLK1 | 1.03508187 |
| 61 | PAK6 | 1.03307496 |
| 62 | PRKD2 | 1.03129616 |
| 63 | SIK3 | 0.99947033 |
| 64 | CDK15 | 0.98497393 |
| 65 | HIPK2 | 0.97127058 |
| 66 | CDK18 | 0.97025245 |
| 67 | MARK2 | 0.96216106 |
| 68 | ERN1 | 0.95738704 |
| 69 | CDK11A | 0.92593706 |
| 70 | PRKCI | 0.91315908 |
| 71 | MARK3 | 0.89458084 |
| 72 | NEK6 | 0.89195039 |
| 73 | MAP3K1 | 0.85799469 |
| 74 | MAP2K6 | 0.84918929 |
| 75 | RAF1 | 0.84743489 |
| 76 | TLK1 | 0.82514879 |
| 77 | IRAK2 | 0.82308723 |
| 78 | BTK | 0.82092435 |
| 79 | WNK1 | 0.81082697 |
| 80 | MAP4K1 | 0.79242342 |
| 81 | CDK5 | 0.78502019 |
| 82 | CAMKK2 | 0.77433784 |
| 83 | NME1 | 0.76856067 |
| 84 | MAPK11 | 0.76449309 |
| 85 | GRK5 | 0.76369908 |
| 86 | ITK | 0.74970669 |
| 87 | GRK7 | 0.72208420 |
| 88 | STK11 | 0.69946765 |
| 89 | PDPK1 | 0.67979069 |
| 90 | DYRK2 | 0.67204424 |
| 91 | RPS6KA5 | 0.66945402 |
| 92 | CAMK2A | 0.66675968 |
| 93 | IRAK1 | 0.64808396 |
| 94 | MAP2K2 | 0.64473462 |
| 95 | PRKCQ | 0.64296144 |
| 96 | CHUK | 0.63516796 |
| 97 | PRKCZ | 0.63384185 |
| 98 | MAP3K11 | 0.62666093 |
| 99 | TBK1 | 0.61915531 |
| 100 | PAK1 | 0.61861462 |
| 101 | STK4 | 0.61570743 |
| 102 | PIM2 | 0.61281146 |
| 103 | LYN | 0.59686280 |
| 104 | ILK | 0.59345813 |
| 105 | PRKAA2 | 0.59183878 |
| 106 | DAPK3 | 0.59059944 |
| 107 | CAMK1 | 0.59044904 |
| 108 | MUSK | 0.57500919 |
| 109 | NTRK3 | 0.55597680 |
| 110 | HCK | 0.54405485 |
| 111 | TEC | 0.54219731 |
| 112 | MOS | 0.53102570 |
| 113 | LRRK2 | 0.52825512 |
| 114 | VRK1 | 0.52443261 |
| 115 | PRKCE | 0.52334897 |
| 116 | FES | 0.52002192 |
| 117 | PIK3CG | 0.51497858 |
| 118 | RPS6KA6 | 0.50547282 |
| 119 | TAOK1 | 0.50042066 |
| 120 | SIK2 | 0.49972778 |
| 121 | MATK | 0.49170065 |
| 122 | PRKD1 | 0.49137076 |
| 123 | TYK2 | 0.49043293 |
| 124 | MAPK13 | 0.47970315 |
| 125 | IKBKE | 0.47687285 |
| 126 | PRKAA1 | 0.47493193 |
| 127 | DAPK2 | 0.47048626 |
| 128 | CSF1R | 0.47044231 |
| 129 | MAP2K1 | 0.46724250 |
| 130 | TYRO3 | 0.46063100 |
| 131 | EIF2AK1 | 0.45315337 |
| 132 | MARK1 | 0.44805797 |
| 133 | PDK1 | 0.44469787 |
| 134 | LCK | 0.43794379 |
| 135 | PRKACA | 0.43349724 |
| 136 | PINK1 | 0.42912565 |
| 137 | PAK3 | 0.42530963 |
| 138 | IRAK4 | 0.41052407 |
| 139 | BLK | 0.41044309 |
| 140 | CDK8 | 0.40277303 |
| 141 | PIM1 | 0.40134003 |
| 142 | BCKDK | 0.38125359 |
| 143 | MAP3K4 | 0.37715641 |
| 144 | GRK6 | 0.35779021 |
| 145 | FGR | 0.35752872 |
| 146 | NTRK2 | 0.34079443 |
| 147 | PRKD3 | 0.33488058 |
| 148 | TGFBR1 | 0.31867708 |
| 149 | JAK3 | 0.31648723 |
| 150 | CSNK1A1 | 0.31391366 |
| 151 | KDR | 0.30808109 |
| 152 | FYN | 0.30350540 |
| 153 | CCNB1 | 0.29831235 |
| 154 | FGFR2 | 0.29329900 |
| 155 | RIPK4 | 0.29168546 |
| 156 | SYK | 0.29068640 |
| 157 | MAP3K7 | 0.29065600 |
| 158 | PRKCG | 0.28599527 |
| 159 | PRKCA | 0.28383139 |
| 160 | AURKA | 0.26925491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.84995162 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.96107236 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.49846611 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.38780743 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.22883658 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 3.02685907 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.95346266 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.74204107 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.69268848 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.67152098 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.63860406 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.62847211 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.40967736 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.40453044 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.37306424 |
| 16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.33068106 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.20773609 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 2.19190984 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.17362326 |
| 20 | Asthma_Homo sapiens_hsa05310 | 2.02469031 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.00962635 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.99861809 |
| 23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.93900329 |
| 24 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.92988610 |
| 25 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.91741412 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.84089207 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.77979568 |
| 28 | GABAergic synapse_Homo sapiens_hsa04727 | 1.71341864 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.68767418 |
| 30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.66028942 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.63660207 |
| 32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.59898655 |
| 33 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.54366491 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50926020 |
| 35 | Huntingtons disease_Homo sapiens_hsa05016 | 1.49098291 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.48538828 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.40508278 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.39013830 |
| 39 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.32724102 |
| 40 | Cocaine addiction_Homo sapiens_hsa05030 | 1.31506898 |
| 41 | Homologous recombination_Homo sapiens_hsa03440 | 1.26229613 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.24122199 |
| 43 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.23695007 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22368697 |
| 45 | Morphine addiction_Homo sapiens_hsa05032 | 1.22073806 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.19260428 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.16720586 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.15575124 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14369145 |
| 50 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.12330186 |
| 51 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.11109323 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10686981 |
| 53 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.10627329 |
| 54 | Long-term depression_Homo sapiens_hsa04730 | 1.06862730 |
| 55 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.02756863 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 1.02177767 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.99602001 |
| 58 | Alcoholism_Homo sapiens_hsa05034 | 0.99137744 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98135981 |
| 60 | Circadian entrainment_Homo sapiens_hsa04713 | 0.94476374 |
| 61 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.94239170 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.93984844 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.92476707 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88134783 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87573444 |
| 66 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.86976434 |
| 67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.85801889 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.83717253 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82243882 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81835527 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78774922 |
| 72 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.78307825 |
| 73 | Insulin secretion_Homo sapiens_hsa04911 | 0.77189350 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.75382566 |
| 75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75092918 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73177619 |
| 77 | Nicotine addiction_Homo sapiens_hsa05033 | 0.71324171 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70149407 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70138068 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68597245 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.67099775 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65318745 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63795175 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63758762 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63100479 |
| 86 | Taste transduction_Homo sapiens_hsa04742 | 0.61335914 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61181833 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.60878932 |
| 89 | Proteasome_Homo sapiens_hsa03050 | 0.60595197 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59622885 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.59532126 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.59196492 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58538601 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58346817 |
| 95 | Salivary secretion_Homo sapiens_hsa04970 | 0.58148247 |
| 96 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.57614402 |
| 97 | Basal transcription factors_Homo sapiens_hsa03022 | 0.56778524 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.56516953 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55498431 |
| 100 | Gap junction_Homo sapiens_hsa04540 | 0.55306464 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53701510 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52424843 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51931496 |
| 104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51916609 |
| 105 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.51169833 |
| 106 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49925758 |
| 107 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48804734 |
| 108 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.46838609 |
| 109 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.45904714 |
| 110 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45703646 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44050399 |
| 112 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43550587 |
| 113 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40814308 |
| 114 | Long-term potentiation_Homo sapiens_hsa04720 | 0.40297458 |
| 115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38213620 |
| 116 | Peroxisome_Homo sapiens_hsa04146 | 0.37461233 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36651684 |
| 118 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36473577 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35323459 |
| 120 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35130792 |
| 121 | Malaria_Homo sapiens_hsa05144 | 0.33462835 |
| 122 | Purine metabolism_Homo sapiens_hsa00230 | 0.32872055 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31797592 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31404423 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.31389155 |
| 126 | Tuberculosis_Homo sapiens_hsa05152 | 0.31286332 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30626443 |
| 128 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30158362 |
| 129 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.29740520 |
| 130 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28798615 |
| 131 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.25491937 |
| 132 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.23994239 |
| 133 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.23669264 |
| 134 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20945924 |
| 135 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20445995 |
| 136 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.19505098 |
| 137 | Olfactory transduction_Homo sapiens_hsa04740 | 0.19012051 |
| 138 | Shigellosis_Homo sapiens_hsa05131 | 0.18602448 |
| 139 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.17697703 |
| 140 | RNA polymerase_Homo sapiens_hsa03020 | 0.17504830 |
| 141 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.15685006 |
| 142 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.15347131 |
| 143 | Mineral absorption_Homo sapiens_hsa04978 | 0.15259005 |
| 144 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14403320 |
| 145 | Prion diseases_Homo sapiens_hsa05020 | 0.13161575 |
| 146 | Tight junction_Homo sapiens_hsa04530 | 0.13132481 |

